ERBB2 and breast carcinoma: Using three human breast cancer cell lines overexpressing or lacking HER2, the in vitro binding capability of Tra‐IR700 to the cell membrane and the cytotoxic effects of Tra‐IR700‐mediated NIR‐PIT were examined.